Aditxt, Inc. Proceeds from Issuance of Warrants
Aditxt, Inc. (ADTX) reported Proceeds from Issuance of Warrants of $129 for the 9-month period ending 2023-09-30, per its 10-Q filed 2024-11-18.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2024-11-18
- Aditxt, Inc. proceeds from issuance of warrants for the quarter ending 2023-09-30 was -$1.58M, a 109.87% decline year-over-year.
- Aditxt, Inc. proceeds from issuance of warrants for the quarter ending 2022-09-30 was $16.03M.
| Period end | Proceeds from Issuance of Warrants 1 month | Proceeds from Issuance of Warrants 3 month | Proceeds from Issuance of Warrants 6 month | Proceeds from Issuance of Warrants 9 month | Proceeds from Issuance of Warrants 9 month as first filed |
|---|---|---|---|---|---|
| 2023-09-30 | -$1.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-18 | $129.00 10-Q · filed 2024-11-18 | $507.02K 10-Q · filed 2023-11-14 | ||
| 2023-06-30 | $1.58M 10-Q · filed 2023-08-14 | ||||
| 2023-04-20 | $1.60M 10-Q · filed 2023-08-14 | ||||
| 2022-09-30 | $16.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $17.23M 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | $1.20M 10-Q · filed 2022-08-15 | ||||
| 2021-09-30 | $10.12M 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |